98 related articles for article (PubMed ID: 4097359)
1. [Effects of SH 582 (gestonorone caproate) for prostatic hypertrophy].
Ochiai K; Komase M; Oshima H; Negishi T; Yamauchi A
Hinyokika Kiyo; 1970 Sep; 16(9):473-81. PubMed ID: 4097359
[No Abstract] [Full Text] [Related]
2. [The clinical effects of SH 582 (gestonorone caproate) on benign prostatic hypertrophy].
Momose S; Hidaka M; Oota Y; Oomaru K
Hinyokika Kiyo; 1970 Sep; 16(9):551-4. PubMed ID: 4097366
[No Abstract] [Full Text] [Related]
3. [Treatment of prostatic hypertrophy with progestational steroid (gestonorone caproate)].
Tanaka H; Fukushige M; Shiraishi T
Hinyokika Kiyo; 1970 Sep; 16(9):531-50. PubMed ID: 4097365
[No Abstract] [Full Text] [Related]
4. [Conservative treatment of benign prostatic hypertrophy with gestagen therapy by gestonorone caproate].
Niijima T; Tanaka H; Takata M
Hinyokika Kiyo; 1970 Sep; 16(9):508-22. PubMed ID: 4097363
[No Abstract] [Full Text] [Related]
5. [Clinical experience with SH-582 for prostatic hypertrophy with special reference to its effects on the thyroid function].
Kuroda K; Nakamura T; Wada I
Hinyokika Kiyo; 1970 Sep; 16(9):482-8. PubMed ID: 4097360
[No Abstract] [Full Text] [Related]
6. [Treatment of prostatic hypertrophy with 19-norhydroxyprogesterone caproate].
Kato T; Okada K
Hinyokika Kiyo; 1970 Sep; 16(9):489-500. PubMed ID: 4097361
[No Abstract] [Full Text] [Related]
7. [Effects of 17-alpha-hydroxy-19-norprogesterone acaproate (SH-582) on prostatic hypertrophy with special reference to estimation of size of the prostate by means of ultrasonotomography].
Watanabe H; Kaiho H; Takahashi H; Kato T; Shima M
Hinyokika Kiyo; 1970 Sep; 16(9):438-45. PubMed ID: 4097357
[No Abstract] [Full Text] [Related]
8. [Treatment of benign prostatic hypertrophy with progestogens including gestonorone caproate].
Nagel R; Hargenda B
Hinyokika Kiyo; 1970 Sep; 16(9):423-8. PubMed ID: 4097356
[No Abstract] [Full Text] [Related]
9. [Progestogen therapy for prostatic hypertrophy].
Tabayashi Y; Kawabata T; Sasaki H
Hinyokika Kiyo; 1970 Sep; 16(9):459-72. PubMed ID: 4097964
[No Abstract] [Full Text] [Related]
10. [Clinical experience with SH 582 for prostatic hypertrophy; comparison with estrogen therapy].
Terao N; Ogawa I; Fujimura N; Kondo K; Tsumagari I
Hinyokika Kiyo; 1970 Sep; 16(9):523-30. PubMed ID: 4097364
[No Abstract] [Full Text] [Related]
11. [Use of 17-alpha-norhydroxy-progesterone caproate (SH 582) in treatment of prostatic hypertrophy].
Hara S; Suemitsu H; Matsuda G; Fukuhara I; Shiba T
Hinyokika Kiyo; 1970 Sep; 16(9):501-7. PubMed ID: 4097362
[No Abstract] [Full Text] [Related]
12. [Clinical experience with SH 582 for prostatic hypertrophy].
Kobayashi C; Miki M
Hinyokika Kiyo; 1970 Sep; 16(9):446-9. PubMed ID: 4097358
[No Abstract] [Full Text] [Related]
13. [Progestogen therapy of benign prostatic hypertrophy].
Nakayama K; Okamoto K
Hinyokika Kiyo; 1970 Sep; 16(9):558-60. PubMed ID: 4097367
[No Abstract] [Full Text] [Related]
14. [Effects of gestonorone caproate on prostate and seminal vesicles of the rat].
Hahn JD
Hinyokika Kiyo; 1970 Sep; 16(9):429-37. PubMed ID: 5528737
[No Abstract] [Full Text] [Related]
15. [On a new synthetic gestagen, gestonorone. Its use in the treatment of prostatic hypertrophy and histological control of its effects on the male gonad].
Luciani L; Frizzi V
Minerva Urol; 1969; 21(6):203-13. PubMed ID: 4104300
[No Abstract] [Full Text] [Related]
16. [Gestagens--an effective conservative treatment of the so-called prostatic hypertrophy?].
Reichelt H
Wien Med Wochenschr; 1970 Nov; 120(45):792-5. PubMed ID: 4103896
[No Abstract] [Full Text] [Related]
17. [Treatment of benign prostatic hypertrophy with gestonorone caproate].
Baranowska B; Kuzaka B
Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):999-1003. PubMed ID: 6209689
[No Abstract] [Full Text] [Related]
18. The effect of 17-alpha-hydroxy-19-norprogesterone caproate (SH582) on benign prostatic hypertrophy.
Aubrey DA; Khosla T
Br J Surg; 1971 Sep; 58(9):648-52. PubMed ID: 4105896
[No Abstract] [Full Text] [Related]
19. [Clinical and cysto-sphincterometric results of progestogen therapy of prostatic adenoma].
Makrigiannis D; Gaca AH
Clin Ter; 1971 Jun; 57(5):399-416. PubMed ID: 4107104
[No Abstract] [Full Text] [Related]
20. Effect of hydroxyprogesterone caproate on experimental benign prostatic obstruction in the mouse.
Caine M; Superstine E
Isr J Med Sci; 1973; 9(11):1559-64. PubMed ID: 4130461
[No Abstract] [Full Text] [Related]
[Next] [New Search]
